Load
Load
About us
Research institute of Regenerative Medicine and Stem Cells
Patients with chronic hepatic disease are about 600 to 800 million people in the world, and it is considered that 3 million people among them can be treated with cell therapy.
NEWS
Physical Performance Decline During the Early Posttransplantation Period Affects Survival After Living Donor Liver Transplantation
2023-03-06NEWS
Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation
2023-03-06NEWS
Ex Vivo Base Editing Therapy with Chemically Derived Hepatic Progenitors
2023-03-06NEWS
Identification of gallbladder cancer by direct nearinfrared measurement of raw bile combined with two-trace two-dimensional correlation analysis
2022-12-27NEWS
Screening of gall bladder cancer through infrared analysis of bile and examination of varied bile constituent composition by the disease
2022-12-19NEWS
Non-Renal Risk Factors for Chronic Kidney Disease in Liver Recipients with Functionally Intact Kidneys at 1 Month
2022-12-19